• Return to Headlines

Shares of Omnicell Has Risen Above Previous 52-Week High

By James Quinn

Omnicell (NASDAQ:OMCL) traded today at a new 52-week high of $43.35. This new high was reached on below average trading volume as 58,000 shares traded hands, while the average 30-day volume is approximately 179,000 shares.

In the past 52 weeks, shares of Omnicell have traded between a low of $25.06 and a high of $43.35 and are now at $43.30, which is 73% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.2% while the 200-day MA has slid 0.5%.

Omnicell (NASDAQ:OMCL) has potential upside of 0.6% based on a current price of $43.30 and analysts' consensus price target of $43.57. The stock should find initial support at its 200-day moving average (MA) of $30.19 and further support at its 50-day MA of $28.18.

Omnicell, Inc. provides an integrated suite of clinical infrastructure and workflow automation solutions for healthcare facilities. The Company's solutions include pharmacy and supply systems, clinical reference tools, an Internet-based procurement application, and decision support tools. Omnicell sells and leases its products and services to a range of healthcare facilities.

SmarTrend recommended that subscribers consider buying shares of Omnicell on January 25th, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $35.22. Since that recommendation, shares of Omnicell have risen 21.6%. We continue to monitor OMCL for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows omnicell

Ticker(s): OMCL